JP2007501288A5 - - Google Patents

Download PDF

Info

Publication number
JP2007501288A5
JP2007501288A5 JP2006536536A JP2006536536A JP2007501288A5 JP 2007501288 A5 JP2007501288 A5 JP 2007501288A5 JP 2006536536 A JP2006536536 A JP 2006536536A JP 2006536536 A JP2006536536 A JP 2006536536A JP 2007501288 A5 JP2007501288 A5 JP 2007501288A5
Authority
JP
Japan
Prior art keywords
amino
salt
dione
phenoxy
methoxycarbonylethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006536536A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007501288A (ja
JP4833072B2 (ja
Filing date
Publication date
Priority claimed from US10/356,113 external-priority patent/US6794401B2/en
Application filed filed Critical
Publication of JP2007501288A publication Critical patent/JP2007501288A/ja
Publication of JP2007501288A5 publication Critical patent/JP2007501288A5/ja
Application granted granted Critical
Publication of JP4833072B2 publication Critical patent/JP4833072B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006536536A 2003-01-17 2004-01-13 アミノ酸フェノキシエーテル Expired - Fee Related JP4833072B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US44077203P 2003-01-17 2003-01-17
US60/440,772 2003-01-17
US10/356,113 2003-01-31
US10/356,113 US6794401B2 (en) 2003-01-17 2003-01-31 Amino acid phenoxy ethers
PCT/US2004/000790 WO2004066964A2 (en) 2003-01-17 2004-01-13 Amino acid phenoxy ethers

Publications (3)

Publication Number Publication Date
JP2007501288A JP2007501288A (ja) 2007-01-25
JP2007501288A5 true JP2007501288A5 (https=) 2008-12-11
JP4833072B2 JP4833072B2 (ja) 2011-12-07

Family

ID=32716922

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006536536A Expired - Fee Related JP4833072B2 (ja) 2003-01-17 2004-01-13 アミノ酸フェノキシエーテル

Country Status (20)

Country Link
US (2) US6794401B2 (https=)
EP (1) EP1583529B9 (https=)
JP (1) JP4833072B2 (https=)
KR (1) KR101085315B1 (https=)
AT (1) ATE532510T1 (https=)
AU (1) AU2004207449A1 (https=)
BR (1) BRPI0406772B1 (https=)
CA (1) CA2513496C (https=)
CY (1) CY1112673T1 (https=)
DK (1) DK1583529T3 (https=)
EA (1) EA200501078A1 (https=)
ES (1) ES2374724T3 (https=)
MA (1) MA27658A1 (https=)
MX (1) MXPA05007684A (https=)
NO (1) NO330984B1 (https=)
NZ (1) NZ541328A (https=)
PT (1) PT1583529E (https=)
SI (1) SI1583529T1 (https=)
TW (1) TWI325420B (https=)
WO (1) WO2004066964A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7521465B2 (en) * 2003-01-17 2009-04-21 Bexel Pharmaceuticals, Inc. Diphenyl ether derivatives
US7781464B2 (en) * 2003-01-17 2010-08-24 Bexel Pharmaceuticals, Inc. Heterocyclic diphenyl ethers
US7087576B2 (en) * 2003-10-07 2006-08-08 Bexel Pharmaceuticals, Inc. Dipeptide phenyl ethers
US7592486B2 (en) * 2004-09-16 2009-09-22 Board Of Regents Of The University Of Nebraska Anhydrous fluoride salts and reagents and methods for their production
EP1858845A2 (en) * 2005-03-18 2007-11-28 Orchid Chemicals and Pharmaceuticals Limited Novel tyrosine derivatives
US20090203744A1 (en) * 2005-07-29 2009-08-13 Pande Y Surendrakumar Satyanarayan Novel pyridine derivatives
EP2066800A2 (en) * 2006-08-04 2009-06-10 Decode Genetics EHF Aryl amino acid derivatives as inhibitors of lta4h (leukotriene a4 hydrolase) for treating inflammation
EP2170306A1 (en) * 2007-06-26 2010-04-07 Lexicon Pharmaceuticals, Inc. Methods of treating serotonin-mediated diseases and disorders
US7875622B2 (en) 2007-07-11 2011-01-25 Lexicon Pharmaceuticals, Inc. Methods and compositions for treating pulmonary hypertension and related diseases and disorders
WO2009030968A1 (en) * 2007-09-05 2009-03-12 Orchid Research Laboratories Limited Mao a inhibitors with a diphenyl ether-substructure.
WO2009143041A1 (en) 2008-05-20 2009-11-26 Merck & Co., Inc. Efficient production of heterologous proteins using mannosyl transferase inhibitors
CN103108634B (zh) 2010-07-28 2015-08-12 幽兰化学医药有限公司 用于治疗肝病、肺病、糖尿病并发症和心血管疾病的二苯醚化合物
US9056862B2 (en) 2011-05-10 2015-06-16 National University Corporation Kobe University Thioxothiazolidine derivative having Ras function inhibitory effect

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020049240A1 (en) * 1994-12-19 2002-04-25 Beecham Group P.1.C. Novel compounds
US5166137A (en) 1991-03-27 1992-11-24 Nobipols Forskningsstiftelse Guluronic acid polymers and use of same for inhibition of cytokine production
US5441971A (en) * 1991-04-11 1995-08-15 The Upjohn Company Thiazolidinedione derivatives, production and use thereof
ES2139633T3 (es) * 1992-08-31 2000-02-16 Sankyo Co Derivados de oxazolidina con propiedades anti-diabetica y anti-obesidad, su preparacion y su utilizacion terapeutica.
TW268952B (https=) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
NZ274346A (en) * 1993-09-15 1997-06-24 Sankyo Co Use of various thiazolidine-2,4-dione and oxazolidine-2,4-dione derivatives to prevent or delay onset of non-insulin dependent diabetes mellitus
US5527546A (en) 1994-08-10 1996-06-18 Bayer Corporation Human interleukin 6 inhibitor
DE4432101A1 (de) * 1994-09-09 1996-03-14 Hoechst Ag Aminosäure-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
ATE271128T1 (de) 1995-05-11 2004-07-15 Applied Research Systems Inhibitoren der il-6 aktivitaet
IL118474A (en) * 1995-06-01 2001-08-08 Sankyo Co Benzimideol derivatives and pharmaceutical preparations containing them
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
TW577875B (en) * 1997-01-31 2004-03-01 Shionogi & Co Pyrrolidine derivatives with inhibitory activity for phospholipase A2
JPH11124331A (ja) * 1997-08-21 1999-05-11 Takeda Chem Ind Ltd 抗炎症剤
US6331633B1 (en) 1998-05-08 2001-12-18 Calyx Therapeutics Inc. Heterocyclic analogs of diphenylethylene compounds
US6699896B1 (en) * 1998-05-12 2004-03-02 Wyeth Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
WO1999064417A2 (en) * 1998-06-05 1999-12-16 Astrazeneca Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
US6664281B1 (en) * 1998-08-27 2003-12-16 Ono Pharmaceutical Co., Ltd. Carboxylic acid derivatives and drugs containing the same as the active ingredient
YU72201A (sh) 1999-04-28 2005-07-19 Aventis Pharma Deutschland Gmbh. Derivati di-aril kiseline kao ppar receptorski ligandi
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
KR20010099634A (ko) 1999-07-01 2001-11-09 할리 켈빈 비. 텔로머라제 저해제 및 그 사용 방법
CN1155586C (zh) * 1999-08-23 2004-06-30 杏林制药株式会社 取代的苄基噻唑烷-2,4-二酮衍生物
JP2003508391A (ja) * 1999-08-31 2003-03-04 マキシア・ファーマシューティカルズ・インコーポレイテッド ベンジリデン−チアゾリジンジオン類およびアナログ類ならびに糖尿病の治療におけるその使用
JP2001199888A (ja) * 2000-01-24 2001-07-24 Fujimoto Brothers:Kk 糖尿病治療剤
JP2001294537A (ja) * 2000-02-10 2001-10-23 Takeda Chem Ind Ltd 併用医薬
EP1148054B1 (en) 2000-04-21 2005-11-23 Pfizer Products Inc. Thyroid receptor ligands
US6680387B2 (en) * 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis

Similar Documents

Publication Publication Date Title
JP2007501288A5 (https=)
US6498174B1 (en) Substituted oxazoles and thiazoles derivatives as hPPARγ and hPPARα activators
DK2038265T3 (en) Inhibitors of human protein tyrosine phosphatase and methods of use
AU773505B2 (en) Arylthiazolidinedione and aryloxazolidinedione derivatives
CN1186489A (zh) N-苄基二氧代噻唑烷基苯甲酰胺衍生物及其制造方法
HUP0400056A2 (hu) Tiazol- vagy oxazolszármazékok, melyek szív-érrendszeri betegségek gyógyítására alkalmazhatók és a vegyületeket tartalmazó gyógyszerkészítmények
JP2010519181A5 (https=)
JP2005524665A (ja) Ppar活性を調節するチアゾールおよびオキサゾール誘導体
JP3373198B2 (ja) アリールチアゾリジンジオン誘導体
WO2012074980A2 (en) Methods of treating or preventing autoimmune disorders and liver disorders using indane acetic acid derivatives
CN100439345C (zh) 作为用于治疗 2型糠尿病和动脉硬化症的ppar调节剂的 3 - ( 2 -苯基 -噁唑-4-基甲氧基)环己基甲氧基乙酸衍生物和相关化合物
JPWO2002051820A1 (ja) ジヒドロナフタレン誘導体化合物およびその化合物を有効成分とする薬剤
AU2001258841B2 (en) Heterocyclic compounds
JP2008530242A5 (https=)
JP2013507397A5 (https=)
TW200418792A (en) Amino acid phenoxy ethers
CN1933833A (zh) 含有噻唑衍生物的含水组合物
WO2010082212A2 (en) N-biphenylacyl thiazolidine-2,4-dione derivatives, their synthesis and uses
RU2006102866A (ru) Тиазолзамещенные индолилпроизводные и их применение в качестве модуляторов ppar
EP2226321A3 (en) Process for producing thiazolidinediones and intermediates thereof
RU2005141516A (ru) Производные анилина
JP3884736B2 (ja) ハロゲノベンジルアミノプロピオン酸誘導体
ZA200204241B (en) Substituted oxazoles and thiazoles derivatives as HPPAR Alpha Activators.
JP4062204B2 (ja) ジヒドロナフタレン誘導体化合物およびその化合物を有効成分とする薬剤
CN1795178A (zh) 由硫脲衍生物合成杂环化合物的方法